Ocugen (OCGN) Assets Growth (1y) (2015 - 2026)

Ocugen (OCGN) Assets Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Ocugen 399.60 Mn 399.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.72%
Dec 31, 2025 -47.22%
Sep 30, 2025 -7.01%
Jun 30, 2025 32.19%
Mar 31, 2025 24.45%
Dec 31, 2024 27.72%
Sep 30, 2024 -17.07%
Jun 30, 2024 -54.43%
Mar 31, 2024 -46.22%
Dec 31, 2023 -40.58%
Sep 30, 2023 -35.75%
Jun 30, 2023 -31.60%
Mar 31, 2023 -32.05%
Dec 31, 2022 2.71%
Sep 30, 2022 -0.06%
Jun 30, 2022 4.70%
Mar 31, 2022 163.20%
Dec 31, 2021 286.33%
Sep 30, 2021 466.28%
Jun 30, 2021 422.97%